Label: LAMISIL AT CREAM- terbinafine hydrochloride cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated October 2, 2025

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Terbinafine hydrochloride 1%

    Purpose

    Antifungal

  • Uses

    •
    cures most athlete's foot (tinea pedis)
    •
    cures most jock itch (tinea cruris) and ringworm (tinea corporis)
    •
    relieves itching, burning, cracking and scaling which accompany these conditions
  • Warnings

    For external use only

    Do not use

    •
    on nails or scalp
    •
    in or near the mouth or eyes
    •
    for vaginal yeast infections

    When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water.

    Stop use and ask a doctor if too much irritation occurs or gets worse

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    •
    adults and children 12 years and over:
    o
    use the tip of the cap to break the seal and open the tube
    o
    wash the affected skin with soap and water and dry completely before applying
    o
    for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily.
    ▪
    between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor
    ▪
    on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor
    o
    for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor
    o
    wash hands after each use
    •
    children under 12 years: ask a doctor
  • Other Information

    •
    do no use if seal on tube is broken or is not visible
    •
    store at controlled room temperature 20-25°C (68-77°F)
  • Inactive Ingredients

    benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol

  • Questions or comments?

    call 1-888-544-1880

  • PACKAGE LABEL.PRINCIPAL DISPLAY

    LAMISILAT
    CREAM
    TERBINAFINE HYDROCHLORIDE
    CREAM 1% - ANTIFUNGAL

    ALL-IN-ONE

    ATHLETE'S FOOT, JOCK ITCH, RINGWORM

    ►Clinically proven to cure most athlete’s foot, jock itch and ringworm

    ► Effective relief of itching, burning, cracking and scaling

    ► FULL PRESCRIPTION STRENGTH


    NET WT 12 g (0.42 oz)

    RECYCLABLE CARTON

    1-888-544-1880

    Distributed By:
    Karo Healthcare Inc.
    Morristown, NJ 07960 USA

    Trademarks owned or
    licensed By Karo Healthcare

    ©2025 Karo Healthcare

    2005210_1 Made in Canada

    Carton-Label

    LAMISILAT CREAM
    TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL
    FOR ATHLETE'S FOOT, JOCK ITCH, RINGWORM

    NET WT
    12g (0.42 oz)

    2005211_1

    Tube-Label
  • INGREDIENTS AND APPEARANCE
    LAMISIL AT CREAM 
    terbinafine hydrochloride cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84485-4030
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE HYDROCHLORIDE1 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    POLYSORBATE 60 (UNII: CAL22UVI4M)  
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    CETYL PALMITATE (UNII: 5ZA2S6B08X)  
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:84485-4030-11 in 1 CARTON10/09/2025
    112 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDANDA02098010/09/2025
    Labeler - Karo Healthcare Inc. (119195452)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!